CR11639A - Compuesto (r)-n*6*-etil-6,7-dihidro-5h-indeno(5,6-d)tiazol-2,6-diamina y su uso como antipsicotico - Google Patents
Compuesto (r)-n*6*-etil-6,7-dihidro-5h-indeno(5,6-d)tiazol-2,6-diamina y su uso como antipsicoticoInfo
- Publication number
- CR11639A CR11639A CR11639A CR11639A CR11639A CR 11639 A CR11639 A CR 11639A CR 11639 A CR11639 A CR 11639A CR 11639 A CR11639 A CR 11639A CR 11639 A CR11639 A CR 11639A
- Authority
- CR
- Costa Rica
- Prior art keywords
- compound
- diamine
- tiazol
- dihidro
- etil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Esta invencion se refiere al compuesto de Formula 1 y sus sales farmaceuticamente aceptables: (R)-N*6*-etil-6,7-dihidro-5H-indenol[5,6-d]tiazol-2,6-diamina. Esta invencion tambien se refiere a metodos para sintetizar, metodos para utilizar y a composiciones farmaceuticas que comprenden el compuesto de Formula 1 y sus sales.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3033208P | 2008-02-21 | 2008-02-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR11639A true CR11639A (es) | 2010-10-05 |
Family
ID=40985770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR11639A CR11639A (es) | 2008-02-21 | 2010-08-20 | Compuesto (r)-n*6*-etil-6,7-dihidro-5h-indeno(5,6-d)tiazol-2,6-diamina y su uso como antipsicotico |
Country Status (24)
Country | Link |
---|---|
US (1) | US20090215841A1 (es) |
EP (1) | EP2254876A4 (es) |
JP (1) | JP2011512407A (es) |
KR (1) | KR20100122487A (es) |
CN (1) | CN101952266A (es) |
AR (1) | AR070618A1 (es) |
AU (1) | AU2009215920A1 (es) |
BR (1) | BRPI0907158A2 (es) |
CA (1) | CA2716215A1 (es) |
CL (1) | CL2009000392A1 (es) |
CO (1) | CO6300849A2 (es) |
CR (1) | CR11639A (es) |
DO (1) | DOP2010000257A (es) |
EA (1) | EA201001095A1 (es) |
EC (1) | ECSP10010412A (es) |
IL (1) | IL206817A0 (es) |
MX (1) | MX2010008923A (es) |
NI (1) | NI201000141A (es) |
PE (1) | PE20091566A1 (es) |
SA (1) | SA109300120B1 (es) |
TW (1) | TW200940516A (es) |
UY (1) | UY31668A1 (es) |
WO (1) | WO2009105026A1 (es) |
ZA (1) | ZA201004800B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017219808A1 (zh) * | 2016-06-21 | 2017-12-28 | 浙江柏拉阿图医药科技有限公司 | 丙型肝炎病毒抑制剂及应用 |
CN109134600B (zh) * | 2017-06-19 | 2021-07-20 | 杭州国谋生物科技有限公司 | 作为丙型肝炎抑制剂的烷基及杂环化合物及其在药物中的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9802360D0 (sv) * | 1998-07-01 | 1998-07-01 | Wikstroem Hakan Vilhelm | New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins ((basic)-N-substituted and (basic)-N,N-disubstituted derivatives of 2,6-diamino-thiazolo(4,5-f)indan and 2,7-di-amino-thiazolo(4,5-g)tetralin |
WO2005084205A2 (en) * | 2004-02-27 | 2005-09-15 | Teva Pharmaceutical Industries, Ltd. | Diamino thiazoloindan derivatives and their use |
-
2009
- 2009-02-18 SA SA109300120A patent/SA109300120B1/ar unknown
- 2009-02-19 US US12/388,548 patent/US20090215841A1/en not_active Abandoned
- 2009-02-20 MX MX2010008923A patent/MX2010008923A/es not_active Application Discontinuation
- 2009-02-20 EP EP09711581A patent/EP2254876A4/en not_active Withdrawn
- 2009-02-20 JP JP2010547592A patent/JP2011512407A/ja active Pending
- 2009-02-20 AR ARP090100601A patent/AR070618A1/es not_active Application Discontinuation
- 2009-02-20 TW TW098105543A patent/TW200940516A/zh unknown
- 2009-02-20 KR KR1020107018569A patent/KR20100122487A/ko not_active Application Discontinuation
- 2009-02-20 UY UY031668A patent/UY31668A1/es not_active Application Discontinuation
- 2009-02-20 EA EA201001095A patent/EA201001095A1/ru unknown
- 2009-02-20 PE PE2009000253A patent/PE20091566A1/es not_active Application Discontinuation
- 2009-02-20 CL CL2009000392A patent/CL2009000392A1/es unknown
- 2009-02-20 AU AU2009215920A patent/AU2009215920A1/en not_active Abandoned
- 2009-02-20 BR BRPI0907158-0A patent/BRPI0907158A2/pt not_active IP Right Cessation
- 2009-02-20 WO PCT/SE2009/050188 patent/WO2009105026A1/en active Application Filing
- 2009-02-20 CA CA2716215A patent/CA2716215A1/en not_active Abandoned
- 2009-02-20 CN CN2009801061103A patent/CN101952266A/zh active Pending
-
2010
- 2010-07-05 IL IL206817A patent/IL206817A0/en unknown
- 2010-07-07 ZA ZA2010/04800A patent/ZA201004800B/en unknown
- 2010-08-20 DO DO2010000257A patent/DOP2010000257A/es unknown
- 2010-08-20 CR CR11639A patent/CR11639A/es not_active Application Discontinuation
- 2010-08-20 NI NI201000141A patent/NI201000141A/es unknown
- 2010-08-20 EC EC2010010412A patent/ECSP10010412A/es unknown
- 2010-08-26 CO CO10105401A patent/CO6300849A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2716215A1 (en) | 2009-08-27 |
US20090215841A1 (en) | 2009-08-27 |
EP2254876A4 (en) | 2012-10-31 |
MX2010008923A (es) | 2010-09-07 |
SA109300120B1 (ar) | 2011-10-08 |
JP2011512407A (ja) | 2011-04-21 |
CN101952266A (zh) | 2011-01-19 |
IL206817A0 (en) | 2010-12-30 |
DOP2010000257A (es) | 2010-10-31 |
BRPI0907158A2 (pt) | 2015-07-07 |
TW200940516A (en) | 2009-10-01 |
PE20091566A1 (es) | 2009-11-06 |
AR070618A1 (es) | 2010-04-21 |
CO6300849A2 (es) | 2011-07-21 |
KR20100122487A (ko) | 2010-11-22 |
ZA201004800B (en) | 2012-06-27 |
EP2254876A1 (en) | 2010-12-01 |
UY31668A1 (es) | 2009-09-30 |
EA201001095A1 (ru) | 2011-04-29 |
AU2009215920A1 (en) | 2009-08-27 |
NI201000141A (es) | 2011-03-24 |
WO2009105026A1 (en) | 2009-08-27 |
ECSP10010412A (es) | 2010-09-30 |
CL2009000392A1 (es) | 2010-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP10010582A (es) | Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer | |
GT200800242A (es) | Derivados biciclicos como inhibidores de cetp | |
CO6321282A2 (es) | Derivados de piperidinilindol como inhibidores de aldosterona sintasa | |
GT200600117A (es) | Nuevos compuestos farmaceuticos | |
CR20140392A (es) | Dihidropirazolonas sustituidas | |
UY30824A1 (es) | Nuevos derivados de idazolil éster o amida, composiciones farmacéuticas conteniéndolas, procesos de preparacion y aplicaciones. | |
SV2008003045A (es) | Aminotetrahidropiranos como inhibidores de dipertidil, peptidasa-iv para el tratamiento o prevencion de diabetes | |
ECSP10010599A (es) | Derivados de tienopiridonas como activadores de proteina quinasa activados por amp (ampk) | |
AR052404A1 (es) | Hidratos y polimorfos de 4-(((7r)-8-ciclopentil-7-etil-5,6,7,8-tetrahidro-5-metil-6-oxo-2-pteridinil)amino)-3- metoxi-n-(1-metil-4-piperidinil)-benzamida, procedimiento para su preparacion y su uso como farmaco | |
CR10662A (es) | Compuestos de metilpiridopirimidinona | |
BRPI0721905B8 (pt) | composto inibidor de proteassoma, sua composição farmacêutica e seu uso | |
UY33337A (es) | DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS | |
ECSP10010271A (es) | Derivados de tiazol usados como inhibidores de pi 3-cinasa | |
UY30748A1 (es) | Compuesto0s novedosos | |
CR10356A (es) | Derivados de 4-benzilphthalazinona 2-sustituidos como antagonistas de histamina h1 y h3 | |
CR11452A (es) | 5-((3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino)-1h-quinolin-2-onas, un proceso para su produccion y su uso como agentes antiflamatorios | |
UY31457A1 (es) | Derivados acidos de cicloalquilamino | |
DOP2006000017A (es) | Pirazolopiridinas y sales de las mismas, una composición farmaceútica que comprende dichos compuestos, un método para prepararlos y su uso | |
ECSP088700A (es) | Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 | |
ECSP099565A (es) | Compuesto de 2-amino pirimidina | |
CR10557A (es) | Bencilaminas, un proceso para la produccion y su uso como agentes antiinflamatorios | |
UY29358A1 (es) | Tiazolidinonas, su preparacion y su uso como medicamento | |
UY32713A (es) | Nuevos agentes antihelmínticos heterocíclicos y su uso. | |
BR112012009311A2 (pt) | composto, composição farmacêutica, e, uso do composto | |
UY32744A (es) | Derivados de 2-carboxamida-7-piperazinil-benzofurano 774 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |